Monte Rosa Therapeutics, Inc.
GLUE
$15.50
-$0.34-2.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 113.74% | 104.32% | 1.33% | 61.55% | 10.83% |
| Total Receivables | 107.59% | 227.34% | 6,605.20% | 734.45% | -75.92% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -17.21% | 40.02% | -12.45% | -33.61% | 11.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 110.84% | 103.91% | 4.17% | 59.95% | 7.76% |
|
|
|||||
| Total Current Assets | 110.84% | 103.91% | 4.17% | 59.95% | 7.76% |
| Net Property, Plant & Equipment | -1.35% | -4.49% | -10.55% | -10.45% | -10.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.90% | 8.63% | 2.49% | 5.80% | 6.31% |
| Total Assets | 92.21% | 87.29% | 2.26% | 45.94% | 4.50% |
|
|
|||||
| Total Accounts Payable | 28.15% | 21.74% | -79.38% | 264.73% | -13.78% |
| Total Accrued Expenses | 95.52% | 82.77% | 62.76% | 17.78% | 13.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.09% | 15.99% | 18.39% | 16.32% | 17.95% |
| Total Finance Division Other Current Liabilities | 20.04% | -0.08% | -74.17% | 30.77% | -7.75% |
| Total Other Current Liabilities | 20.04% | -0.08% | -74.17% | 30.77% | -7.75% |
| Total Current Liabilities | 42.55% | 19.96% | -59.09% | 47.55% | -1.17% |
|
|
|||||
| Total Current Liabilities | 42.55% | 19.96% | -59.09% | 47.55% | -1.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.94% | -8.99% | -10.79% | -10.30% | -9.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 778.70% | 422.93% | 487.42% | 317.59% | -65.16% |
| Total Liabilities | 122.81% | 81.73% | -0.09% | 95.22% | -23.39% |
|
|
|||||
| Common Stock & APIC | 56.57% | 56.43% | 7.40% | 3.09% | 3.04% |
| Retained Earnings | -39.88% | -33.19% | -8.81% | 4.63% | 5.64% |
| Treasury Stock & Other | -53.13% | -42.57% | -14.03% | -39.84% | -26.33% |
| Total Common Equity | 81.77% | 89.68% | 4.54% | 19.65% | 19.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 81.77% | 89.68% | 4.54% | 19.65% | 19.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 81.77% | 89.68% | 4.54% | 19.65% | 19.32% |
|
|
|||||